Drug profile

The FDA adverse-event record for Glucosamine/ Chondroitin/ Avocado/Soybean Unsaponifiables/ Decaffeinated Tea Joint Supplement

15 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Glucosamine/ Chondroitin/ Avocado/Soybean Unsaponifiables/ Decaffeinated Tea Joint Supplement. See the species affected, top reactions, and outcomes below.

15
adverse-event reports
6.7%
death-coded share
Dog
most-reported species
5
Arthritis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
1
Deaths Reported
6.7%
Death Rate

Active Ingredients

Glucosamine/ Chondroitin/ Avocado/Soybean Unsaponifiables/ Decaffeinated Tea Joint Supplement

Administration Routes

Unknown

Species Affected

Dog 15

Most Affected Breeds

Retriever - Labrador 9
Retriever - Golden 2
Shepherd Dog - German 1
Great Pyrenees 1
Havanese 1
Dog (unknown) 1

Most Reported Reactions

Arthritis 5
Lack of efficacy (endoparasite) - heartworm 3
Lack of efficacy (bacteria) - Borrelia 3
Limping 3
Vomiting 2
Elevated serum alkaline phosphatase (ALP) 2
Lack of efficacy - NOS 2
Application site hair loss 1
Application site erythema 1
Application site infection 1
Lot # and/or Expiration date illegible 1
Diarrhoea 1

Outcome Breakdown

Outcome Unknown
8 (53.3%)
Ongoing
5 (33.3%)
Died
1 (6.7%)
Recovered/Normal
1 (6.7%)

Glucosamine/ Chondroitin/ Avocado/Soybean Unsaponifiables/ Decaffeinated Tea Joint Supplement Adverse Event Insights

15 reports name Glucosamine/ Chondroitin/ Avocado/Soybean Unsaponifiables/ Decaffeinated Tea Joint Supplement; 1 recorded a death outcome (6.7% of reported events, not a population-level mortality rate). Active ingredient: Glucosamine/ Chondroitin/ Avocado/Soybean Unsaponifiables/ Decaffeinated Tea Joint Supplement. Administration route: Unknown.

By species: Dog (15 reports). By breed: Retriever - Labrador (9), Retriever - Golden (2), Shepherd Dog - German (1).

Leading clinical signs: Arthritis (5), Lack of efficacy (endoparasite) - heartworm (3), Lack of efficacy (bacteria) - Borrelia (3), Limping (3). Outcome, 15 coded reports: Outcome Unknown leads at 53.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.